Back to companies
Spero Therapeutics, Inc.
SPROUSNASDAQPharmaceuticals & HealthcareSpero Therapeutics, Inc.
Revenue
$12.6mn
YoY +3292.5%
Operating income
$6.3mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API